197 related articles for article (PubMed ID: 12002518)
1. Role of benzodiazepine-GABAA receptor complex in attenuation of U-50,488H-induced analgesia and inhibition of tolerance to its analgesia by ginseng total saponin in mice.
Nemmani KV; Ramarao P
Life Sci; 2002 Mar; 70(15):1727-40. PubMed ID: 12002518
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rf potentiates U-50,488H-induced analgesia and inhibits tolerance to its analgesia in mice.
Nemmani KV; Ramarao P
Life Sci; 2003 Jan; 72(7):759-68. PubMed ID: 12479975
[TBL] [Abstract][Full Text] [Related]
3. Ginseng total saponin potentiates acute U-50,488H-induced analgesia and inhibits tolerance to U-50,488H-induced analgesia in mice.
Nemmani KV; Ramarao P
Pharmacol Biochem Behav; 2002 May; 72(1-2):1-6. PubMed ID: 11900762
[TBL] [Abstract][Full Text] [Related]
4. Melatonin inhibits the development of tolerance to U-50,488H analgesia via benzodiazepine-GABAAergic mechanisms.
Dhanaraj E; Nemmani KV; Ramarao P
Pharmacol Biochem Behav; 2004 Dec; 79(4):733-7. PubMed ID: 15582681
[TBL] [Abstract][Full Text] [Related]
5. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia.
Nemmani KV; Mogil JS
Neuropharmacology; 2003 Mar; 44(3):304-10. PubMed ID: 12604090
[TBL] [Abstract][Full Text] [Related]
7. Majonoside-R2, a major constituent of Vietnamese ginseng, attenuates opioid-induced antinociception.
Huong NT; Matsumoto K; Yamasaki K; Duc NM; Nham NT; Watanabe H
Pharmacol Biochem Behav; 1997; 57(1-2):285-91. PubMed ID: 9164584
[TBL] [Abstract][Full Text] [Related]
8. The possible involvement of GABAA systems in the antinarcotic effect of majonoside-R2, a major constituent of Vietnamese ginseng, in mice.
Nguyen TT; Matsumoto K; Yamasaki K; Nguyen MD; Nguyen TN; Watanabe H
Jpn J Pharmacol; 1996 Aug; 71(4):345-9. PubMed ID: 8886934
[TBL] [Abstract][Full Text] [Related]
9. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
Lutfy K; Doan P; Nguyen M; Weber E
Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
[TBL] [Abstract][Full Text] [Related]
10. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Gullapalli S; Ramarao P
Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
[TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
[TBL] [Abstract][Full Text] [Related]
12. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia.
Lawson KP; Nag S; Thompson AD; Mokha SS
Pain; 2010 Dec; 151(3):806-815. PubMed ID: 20926192
[TBL] [Abstract][Full Text] [Related]
13. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.
Chen C; Chiu YT; Wu W; Huang P; Mann A; Schulz S; Liu-Chen LY
Biochem J; 2016 Feb; 473(4):497-508. PubMed ID: 26635353
[TBL] [Abstract][Full Text] [Related]
14. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
Zhang F; Li J; Li JG; Liu-Chen LY
J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
[TBL] [Abstract][Full Text] [Related]
15. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of U-50,488H-induced antinociception by ginseng total saponins is dependent on serotonergic mechanisms.
Kim HS; Oh KW; Rheu HM; Kim SH
Pharmacol Biochem Behav; 1992 Aug; 42(4):587-93. PubMed ID: 1513840
[TBL] [Abstract][Full Text] [Related]
18. Involvement of supraspinal GABA receptors in majonoside-R2 suppression of clonidine-induced antinociception in mice.
Nguyen TT; Matsumoto K; Yamasaki K; Watanabe H
Life Sci; 1997; 61(4):427-36. PubMed ID: 9244369
[TBL] [Abstract][Full Text] [Related]
19. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
Bhargava HN; Thorat SN
Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
